Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study
法米替尼联合同步放化疗治疗局部晚期鼻咽癌患者:一项1期开放标签剂量递增研究
期刊:Cancer Communications
影响因子:24.9
doi:10.1186/s40880-018-0330-z
Chen, Qiuyan; Tang, Linquan; Liu, Na; Han, Feng; Guo, Ling; Guo, Shanshan; Wang, Jianwei; Liu, Huai; Ye, Yanfang; Zhang, Lu; Liu, Liting; Wang, Pan; Li, Yingqin; He, Qingmei; Yang, Xiaoqun; Tang, Qingnan; Li, Yang; Liang, YuJing; Sun, XueSong; Xie, Chuanmiao; Mo, Yunxian; Guo, Ying; Sun, Rui; Mo, Haoyuan; Cao, Kajia; Guo, Xiang; Zeng, Musheng; Mai, Haiqiang; Ma, Jun